Gary Fletcher focuses on driving growth by creating new products and business models, developing technologies into new products to meet customers’ needs. He is an accomplished R&D leader, with extensive experience in new product development, most recently in medical devices for point of care and cancer diagnostics. He has expertise in determining customer needs, assessing new technologies, and building and managing teams developing business cases and new products.


Physical and Life Sciences; Strategic Innovation; New Product Development; Technology and IP Assessment


Gary also serves as Principal at RNDDx Solutions, a consultancy he formed to help companies drive growth by creating innovative business and technology opportunities, and by improving their innovation culture, processes, and strategy. To “practice what he preaches”, Gary also serves at the CEO of SphereVis, LLC, a Penn Center for Innovation start-up, developing a simple optical super resolution microscopy method of imaging biological structures. At BD [Becton Dickinson], an $8+ billion Fortune 500 company, Gary served as Leader, Technology Innovation and was responsible for developing and executing two business plans and technology strategies, generating $2M internal investment for technology development. These efforts included identifying and engaging academic and commercial thought leaders and customers to provide product concept feedback, and managing external technology consultants, in materials and microfluidics for disposable medical devices. Earlier in his BD career Gary was Director, Core Technologies, and spearheaded BD Preanalytical Systems “deep dive” technology assessment of blood fractionation technologies, providing understanding of, and capabilities in, new separation technologies critical to next generation blood diagnostics. As Technical Manager of Healthcare Products at Sarnoff Corporation, Gary managed a minimally invasive blood glucose monitor product development effort, spinning out a medical device startup company. At the medical imaging startup company Cytometrics Gary served as VP of Engineering and VP of Advanced Technology, leading the effort to create multiple generations of prototype miniature optical microscopes, and meeting milestones generating $51M in angel investment for product development and commercialization. Early in his career, Gary developed near- and mid-infrared spectroscopy instruments for medical diagnostics and process control; and in developing laser spectroscopy and x-ray spectroscopy methods, at both manufacturing companies and Lawrence Livermore National Laboratory. Gary holds a Ph.D. in physics from Yale University, and a Bachelor of Arts degree in Physics and Mathematics from DePauw University. He is currently serving as the industry mentor to academic researchers in the NSF-sponsored I-Corps [Innovation Corps] program, a rigorous methodology for academics to assess the market potential of, and customer needs in, product concepts arising from NSF-funded research.